U.S. flag

An official website of the United States government

NM_001386393.1(PANK2):c.740G>C (p.Arg247Pro) AND Pigmentary pallidal degeneration

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
Nov 17, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000990272.11

Allele description [Variation Report for NM_001386393.1(PANK2):c.740G>C (p.Arg247Pro)]

NM_001386393.1(PANK2):c.740G>C (p.Arg247Pro)

Gene:
PANK2:pantothenate kinase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
20p13
Genomic location:
Preferred name:
NM_001386393.1(PANK2):c.740G>C (p.Arg247Pro)
HGVS:
  • NC_000020.11:g.3910665G>C
  • NG_008131.3:g.26827G>C
  • NM_001324191.2:c.197G>C
  • NM_001324193.2:c.-239G>C
  • NM_001386393.1:c.740G>CMANE SELECT
  • NM_024960.6:c.197G>C
  • NM_153638.4:c.1070G>C
  • NM_153640.4:c.197G>C
  • NP_001311120.1:p.Arg66Pro
  • NP_001373322.1:p.Arg247Pro
  • NP_079236.3:p.Arg66Pro
  • NP_705902.2:p.Arg357Pro
  • NP_705904.1:p.Arg66Pro
  • LRG_1016t1:c.1070G>C
  • LRG_1016t2:c.740G>C
  • LRG_1016:g.26827G>C
  • LRG_1016p1:p.Arg357Pro
  • LRG_1016p2:p.Arg247Pro
  • NC_000020.10:g.3891312G>C
  • NM_153638.2:c.1070G>C
  • NM_153638.3:c.1070G>C
  • NR_136715.2:n.641G>C
Protein change:
R247P
Links:
dbSNP: rs754521581
NCBI 1000 Genomes Browser:
rs754521581
Molecular consequence:
  • NM_001324193.2:c.-239G>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001324191.2:c.197G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386393.1:c.740G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_024960.6:c.197G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_153638.4:c.1070G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_153640.4:c.197G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_136715.2:n.641G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Pigmentary pallidal degeneration (NBIA1)
Synonyms:
PKAN NEUROAXONAL DYSTROPHY, JUVENILE-ONSET; Pantothenate kinase-associated neurodegeneration; Neuroaxonal dystrophy, late infantile; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009319; MedGen: C0018523; Orphanet: 157850; OMIM: 234200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001141200Mendelics
criteria provided, single submitter

(Mendelics Assertion Criteria 2017)
Likely pathogenic
(May 28, 2019)
unknownclinical testing

Citation Link,

SCV001391682Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 17, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

SCV002599022Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Sep 22, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation.

Hartig MB, Hörtnagel K, Garavaglia B, Zorzi G, Kmiec T, Klopstock T, Rostasy K, Svetel M, Kostic VS, Schuelke M, Botz E, Weindl A, Novakovic I, Nardocci N, Prokisch H, Meitinger T.

Ann Neurol. 2006 Feb;59(2):248-56.

PubMed [citation]
PMID:
16437574

Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations.

Leoni V, Strittmatter L, Zorzi G, Zibordi F, Dusi S, Garavaglia B, Venco P, Caccia C, Souza AL, Deik A, Clish CB, Rimoldi M, Ciusani E, Bertini E, Nardocci N, Mootha VK, Tiranti V.

Mol Genet Metab. 2012 Mar;105(3):463-71. doi: 10.1016/j.ymgme.2011.12.005. Epub 2011 Dec 14.

PubMed [citation]
PMID:
22221393
PMCID:
PMC3487396
See all PubMed Citations (5)

Details of each submission

From Mendelics, SCV001141200.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001391682.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 357 of the PANK2 protein (p.Arg357Pro). This variant is present in population databases (no rsID available, gnomAD 0.003%). This missense change has been observed in individuals with clinical features of neurodegeneration with brain iron accumulation (PMID: 15911822; Invitae). This variant is also known as c.G740C, p.R247P. ClinVar contains an entry for this variant (Variation ID: 803594). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PANK2 protein function. This variant disrupts the p.Arg357 amino acid residue in PANK2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16437574, 22221393, 28680084). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002599022.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: PANK2 c.1070G>C (p.Arg357Pro) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251366 control chromosomes. c.1070G>C has been reported in the literature in individuals affected with Pantothenate Kinase-Associated Neurodegeneration (Pelleccia_2005). These data indicate that the variant is likely to be associated with disease. Additionally, two other variants at the same codon have been reported in association with Pantothenate kinase-associated neurodegeneration in HGMD (R357Q, R357W), supporting pathogenicity. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as likely pathogenic, and one classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024